Despite diagnostic performance limitations, urine lipoarabinomannan (LAM) predicts death in human immunodeficiency virus (HIV)–infected adults with tuberculosis. Pediatric data are limited. Among 137 hospitalized HIV-infected children, mortality was 4.9-fold higher among those with positive LAM (127 vs 31 per 100 person-years; adjusted hazard ratio, 4.92; 95% confidence interval [CI], 1.79–13.49; P = .002). Lipoarabinomannan identifies HIV-infected children at risk for death potentially missed by respiratory sampling.

中文翻译：

---

尿结核Lipoarabinomannan预测住院的人类免疫缺陷病毒感染儿童的死亡率。

尽管诊断性能受到限制，但尿脂阿拉伯糖甘露聚糖（LAM）仍可预测感染了人类免疫缺陷病毒（HIV）的成年人的死亡。儿科数据有限。在137名接受HIV感染的住院儿童中，LAM阳性的儿童的死亡率高4.9倍（每100人年127比31；调整后的危险比为4.92； 95％置信区间[CI]为1.79–13.49；P =。 002）。Lipoarabinomannan识别出呼吸道采样可能遗漏的有HIV感染危险的儿童死亡。